Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Mar 1, 2026 9:00 AM ・ Updated Jun 1, 2026 1:10 PM ・ 2 min read ・ Source: PR Times
TaiGen Biotechnology announced its March 2026 revenue of 115 million yuan, marking a significant 28.2% increase compared to the same period last year. This strong performance in the biotechnology and healthcare sector highlights the company's robust growth and expanding market presence.
Company Code: 6589 Company Name: TaiGen Biotechnology Industry Sector: Biotechnology and Healthcare Data Month: 2026-03 Monthly Revenue: 114,712 thousand yuan (115 million yuan) Year-on-Year Change: +28.2%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.